Aspen sails through debut €3bn euro loan with strong demand
Johannesburg-listed drug manufacturer Aspen Pharmacare completed arranging €3bn-equivalent of loans on Wednesday. The multicurrency deal was more than twice oversubscribed in the euro tranche.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: